|
|
|
|
Vol. 56, Issue 4, 841-848, October 1999
St. Jude Children's Research Hospital, and Colleges of Pharmacy and Medicine, University of Tennessee, Memphis, Tennessee (N.F.K., E.Y.K., W.E.E.); and Chemistry Department, Moscow State University, Moscow, Russia (N.F.K.)
| |
Summary |
|---|
|
|
|---|
Mercaptopurine and thioguanine are anticancer and immunosuppressive agents that exert their primary cytotoxic effects via incorporation of deoxythioguanosine (dGs) into DNA, but the precise mechanism(s) by which this causes cytotoxicity remains unknown. We initially determined that the level of dGs incorporation into DNA of human T- and B-lineage leukemia cell lines did not correlate significantly with the extent of cytotoxicity (IC50), except that there was no cytotoxicity in the absence of dGs incorporation. To elucidate biological processes perturbed by dGs incorporation into DNA, we chemically synthesized oligodeoxyribonucleotides containing a single dGs (11 mer and 19 mer), which decreased the melting temperature (Tm) of DNA-DNA duplexes without major structural changes, as evidenced by circular dichroism spectra. Using nuclear extracts from human lymphoblastic leukemia cells (CCRF-CEM, NALM6, and Molt4), we documented that dGs incorporation into the DNA strand of DNA-RNA heteroduplexes significantly inhibited human RNase H-catalyzed RNA cleavage (80-90% inhibition) and that a similar inhibition was evident with bacterial RNase H. These data provide the first evidence that thiopurines inhibit the function of RNase H, indicating that their mechanism of cytotoxicity may involve interference with this component of the replication machinery.
| |
Introduction |
|---|
|
|
|---|
Mercaptopurine
(MP) is an important antileukemic agent used in the majority of modern
treatment regimens for acute lymphoblastic leukemia (ALL) (Elion,
1989
). Whereas current therapy can cure >75% of children with ALL
(Pui and Evans, 1998
), chemotherapy resistance leads to relapse in a
substantial number of patients. In contrast to some human leukemia cell
lines, in which resistance to thiopurines is acquired via inactivation
of hypoxanthine-guanine phosphoribosyl transferase (HPRT), no clear
relation has been found between HPRT activity and in vitro resistance
to thiopurines in primary leukemia cells from patients with ALL
(Pieters et al., 1992
). New insights into mechanism(s) of thiopurine
cytotoxicity and resistance are therefore needed to facilitate further
improvements in the use of these medications.
Cytotoxic effects of MP and 6-thioguanine (TG) are achieved primarily
through 6-deoxythioguanosine (dGs) incorporation
into DNA (LePage, 1963
), an essential feature of the delayed
cytotoxicity produced by these agents. Inhibition of
dGs incorporation (e.g., with mycophenolic acid,
hydroxyurea, 1-
-D-arabinofuranosyl cytosine, or
5-fluorodeoxyuridine) protects cells against the delayed lethal effects
of MP (Tidd and Paterson, 1974a
,b
; Lee and Sartorelli, 1981
). A number
of anticancer drugs other than thiopurines induce delayed cytotoxic
effects; a common property of these agents is their potential to alter
DNA structure (Maybaum and Mandel, 1983
).
Treatment of cells with TG produces severely disrupted chromatin during
G2 of the cell cycle, as visualized by premature
chromosome condensation (Maybaum and Mandel, 1981
, 1983
). Chromatid
damage is a dose-related effect, appearing as sharp curling or
"kinking" of chromatid at lower TG concentrations and as unilateral
chromatid damage and gross chromosome disruption at higher TG
concentrations (Maybaum and Mandel, 1983
).
During replication, different components of the replication complex
(synthesome) interact with single-stranded DNA, double-stranded DNA,
and with hybrid DNA-RNA duplexes. It is postulated that
dGs incorporated into DNA may alter these
interactions and thereby inhibit normal DNA replication. Previous
studies have demonstrated that dGs incorporation
into DNA partially inhibits the activity of DNA polymerases and DNA
ligase (Ling et al., 1992
). In the present study, we provide the first
evidence that dGs incorporation into DNA
significantly inhibits the activity of RNase H, another critical enzyme
participating in DNA replication.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals and Reagents. Dulbecco's PBS, tris(hydroxymethyl) aminomethane (Tris-HCl), ammonium phosphate, MP, Escherichia coli RNase H, bacterial alkaline phosphatase, proteinase K, and phosphodiesterase I were obtained from Sigma Chemical Company (St. Louis, MO). RNase-free DNase I from bovine pancreas (6000 activity units/25 µl) was purchased from Stratagene (La Jolla, CA). dGs was the generous gift of J. J. Johnson, Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute. N-[6,7-Amino-4-methylcoumarin-3-acetamidohexyl]-3'-(2'-pyridylthio)propil-amide (AMCA) was purchased from Pierce Chemical Co. (Rockford, IL). S6-Dinitrophenol-dG-cyanoethyl phosphoroamidite was obtained from Glen Research (Sterling, VA).
The human T cell leukemia cell lines CCRF-CEM and Molt4 and human B-lineage WIL2-NS (B lymphoblast) and WIL2-S (B lymphoblast) cells were obtained from American Type Culture Collection (Rockville, MD). The human T cell leukemia P12, CCRF-CEM with inactivated HPRT (HPRT-deficient CEM), pre- B cell leukemia 697, and B-lineage NALM6 cell lines were obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany). Cell number and viability were determined in duplicate in a Burker-Turk chamber using trypan blue exclusion. Cells in logarithmic phase (doubling time about 24 h) were suspended in fresh medium with 10% fetal bovine serum (Biowhittaker, Walkersville, MD). All experiments were started with an initial concentration of 0.25 × 106 cells/ml before addition of MP, which was dissolved in medium and added as a single dose to achieve a final concentration of 10 µM drug in the culture medium (determined by optical density at 320 nm). Cytotoxicity was expressed as a ratio of viable cells incubated with MP (i.e., cell count × % of viable cells) to the number of viable cells (cell count × % of viable cells) in the control (without MP).Isolation of dGs-Containing Genomic DNA. Genomic DNA was isolated from 5 × 106 cells after 0 to 48 h of incubation of cells with 10 µM MP, using the QIAGEN cell culture DNA kit (QIAGEN, Chatsworth, CA), according to the manufacturer's instructions. In brief, nuclei were isolated by centrifugation after lysis of cell membranes. The nuclear pellets were then lysed by sonication (30 s) and treated with proteinase K for 50 min at 50°C. Genomic DNA was isolated by adsorption to the QIAGEN column. DNA solution was treated with DNase I (30 min at 37°C) and then with a mixture of phosphodiesterase I and bacterial alkaline phosphatase (16 h at 50°C).
Quantitation of dGs in Genomic DNA by UV
Absorbance.
After enzymatic hydrolysis of DNA, reaction mixtures
were injected onto a Supelcosil LC-18C column
(250 × 4.6 mm; Supelco Inc., Bellefonte, PA) and separated using
a gradient of methanol (3-20%) in 3 mM ammonium phosphate, pH 3.7 (Gehrke et al., 1983
). The eluate composition was monitored by UV
detection at 340 nm. Extinction coefficient 24.8 × 103 at 56 max 340 nm was
used to determine dGs concentrations (Merck & Co., Inc., 1989
). The amount of dGs was
calculated using a calibration curve with dGs
(7.5-75 pmol) as a reference standard.
Fluorometric Quantitation of dGs in Genomic DNA.
The resulting mixture of nucleosides, after completion of hydrolysis,
was treated with AMCA as described (Warren et al., 1995
). The
derivatized products were injected onto the Supelcosil LC-8 (150 × 4.6 mm) column (Supelco Inc.) and separated using isocratic elution
with 0.2 M sodium formate buffer, pH 4.0, methanol (63:37, v/v) for 20 min. The column was then washed with sodium formate/methanol (20:80,
v/v) for 12 min. The dGs-AMCA derivative was detected
using the fluorometer at an excitation wavelength of 345 nm and
emission of 450 nm. Quantification was achieved by using a calibration
curve with dGs (0.1-10 pmol) as a reference standard.
HPRT Activity. HPRT activity in cell lysates was estimated by formation of [14C]inosine monophosphate from [14C]hypoxanthine according to the following protocol: 20 µl cell lysate, 10 µl water, and 70 µl cocktail (20 µl 0.5 M glycine buffer, 10 µl 10 mM 5-phosphoribosyl-1-pyrophosphate, 10 µl 50 mM MgCl2, 10 µl 1.5 mM [14C]hypoxanthine, and 20 µl water) were mixed and incubated for 15 min at room temperature. The reaction was stopped by placing mixtures on ice and adding 5 µl of 0.25 M EDTA. Ten microliters of sample mixture or standard (containing the known amount of [14C]inosine monophosphate) were spotted on polyethyleneimine cellulose paper, dried, and washed in 1 mM NH4HCO3 and water. The bound radioactivity was counted in 20 ml of Scint A-X-F (Packard, Meriden, CT).
Thiopurine Methyltransferase (TPMT) Activity.
TPMT activity
in cell lysates was determined by the nonchelated radiochemical assay
of Weinshilboum et al. (1978)
, as previously reported by our lab
(McLeod et al., 1994
).
Modified and Nonmodified Oligodeoxyribonucleotides.
Oligodeoxyribonucleotides were synthesized using standard protocols
with an automatic synthesizer (Applied Biosystems, Foster City, CA).
The syntheses of modified oligodeoxyribonucleotides 5'-d(ACCACCGsCGCT) and
5'-d(TTGCCTTTAAGGsAAAGTAT) containing
dGs were accomplished using standard
phosphoroamidite chemistry with S6-dinitrophenol-dG-cyanoethyl
phosphoroamidite (Glen Research) and isolated by HPLC (Altex
Electronics, San Antonio, TX; Xu et al., 1992
). Purity of the
oligonucleotides was estimated to be 99.5% by ion-pair HPLC (Waters,
Milford, MA) using an Armsorb C16 (7.5 µm) column
(4 × 250 mm), eluted with 50 mM potassium phosphate buffer, pH
7.0, containing 2 mM tetrabutylammonium phosphate with a logarithmic
acetonitrile concentration gradient from 5 to 40% over 40 min (flow
rate, 1 ml/min) at 47°C.
260) were used for nucleotides: pA, 15,400;
pT, 9,300; pU, 8,800; pC, 7,300; and pG, 11,700. The molar extinction
coefficient (
340) 24,800 was used for
thioguanosine (Merck & Co., Inc., 1989Physicochemical Characterization of Gs-Containing Duplexes. Stability of dGs-modified duplexes (I-IV) was assessed by the temperature dependence of the UV absorption of heteroduplexes, with continuous increase of the temperature at a rate of 0.5°C/min. Changes in optical density of the solution were monitored with a Hitachi model 150-20 spectrophotometer (Tokyo, Japan), using thermostatically controlled quartz cuvettes with a path length of 10 mm. The increase in UV absorbance at 260 nm (At-A0) was monitored, and A0 immediately after enzyme addition was adjusted to zero.
Circular dichroism spectra from 320 to 220 nm were recorded at 21°C, with a dichrograph Roussel-Jouan III (Marcel, France). The cell compartment was continuously purged with dry N2. Digitized data obtained at every nanometer of wavelength were corrected for baseline and smoothed by a least-squares polynomial fit up to the third order. CD spectra per mole of monomer were plotted as
L-
R in units of
liter × mole
1 × centimeter
1.
Nuclear Extracts from Cell Lines.
Nuclear extracts were
prepared according to Dignam et al. (1983)
. Briefly, approximately
1 × 108 cells were collected by
centrifugation (700g, 10 min at 4°C), washed in 10 ml of
PBS, and resuspended in 700 µl of buffer A [10 mM HEPES, pH 7.9 (4°C), 1.5 mM MgCl2, 10 mM KCl, and 0.5 mM dithiothreitol (DTT)]. After incubation on ice for 10 min,
cells were collected by centrifugation, suspended in 280 µl of buffer A, and lysed by 10 to 20 strokes of a Kontes all-glass Dounce homogenizer (B type pestle, 1 ml capacity). The lysate was centrifuged for 20 min at 25,000g (Ti70.1 rotor) at 4°C. The pellet of
crude nuclei was resuspended in 300 µl buffer C [20 mM HEPES, pH 7.9 (4°C), 1.5 mM MgCl2, 0.42 M KCl, 0.2 mM EDTA,
25% glycerol, 0.5 mM DTT, and 0.5 mM phenylmethylsulfonyl fluoride),
resuspended by 10 to 20 strokes of a Kontes all-glass Dounce
homogenizer (B type pestle, 1 ml capacity), and the resulting
suspension was extracted by gentle stirring for 30 min on ice with a
magnet stirrer. The resulting suspension was centrifuged for 30 min at
25,000g (Ti70.1 rotor) at 4°C, and the clear supernatant
was dialyzed against buffer D [20 mM HEPES, pH 7.9 (4°C), 0.1 M KCl,
0.2 mM EDTA, 20% glycerol, 0.5 mM DTT, and 0.5 mM phenylmethylsulfonyl fluoride) for 5 h. The preparation was aliquoted, snap-frozen in
liquid nitrogen, and kept at
70°C. Protein concentration was determined using the Bradford method (Bio-Rad, Hercules, CA).
RNase H Catalyzed Cleavage of RNA Strand of Hybrid Duplexes.
Hydrolysis of the heteroduplexes by ribonuclease H (RNase H) was
carried out in 10 µl 0.02 M Tris-HCl buffer, pH 7.9, containing 0.15 M NaCl, 11 mM MgCl2, 0.5 mM DTT, 1 mM EDTA using
a 5'- or 3'- [32P]RNA strand (Schmidt et al.,
1992
). The reaction was initiated by adding 2 µl E. coli
RNase H (final concentration, 2.5 nM) or 2 µl of nuclear extract
(4-8 µg protein). The reaction was carried out at 20°C for 10 to
60 min. The reaction was terminated by adding 5 µl of 3 M sodium
acetate, 1 µl of tRNA (5 µg/µl), and 100 µl of cold ethanol.
The mixture was incubated at
70°C overnight and the precipitate was
collected by centrifugation. Cleavage products were analyzed by
electrophoresis in 12 or 20% polyacrylamide gel (PAAG) and quantitated
by a Molecular Dynamics (Sunnyvale, CA) PhosphorImager system.
Statistical Analysis. Cell viability and dGs incorporation among different cell lines were compared using ANOVA, followed by the Tukey multiple comparison test. Spearman rank order correlation was used to assess the relation between dGs incorporation and cytotoxicity. ANOVA was used to compare differences in RNase H-mediated RNA hydrolysis within heteroduplexes that did versus did not contain a dGs inserts. Computations were performed with STATISTICA, version 5.1 (StatSoft Inc., Tulsa, OK), and p < .05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
Cell Viability.
The effects of 10 µM MP incubation on cell
viability of human T-lineage lymphoblastic leukemia cells (CEM,
HPRT-deficient CEM, Molt4, and P12) and human B-lineage lymphoblastic
leukemia (NALM6, WIL2S, and WIL2NS, 697) are shown in Fig.
1A. There were significant differences in
cytotoxicity among these cell lines after exposure to 10 µM MP for 48 and 72 h (ANOVA, p < .03), but little or no
difference after 24 h of exposure to MP (Fig. 1). As anticipated,
the HPRT-deficient cell lines (HPRT-deficient CEM and WIL2S) used as
negative controls in these experiments, were not sensitive to MP
treatment.
|
dGs Incorporation into Genomic DNA.
Incorporation
of dGs into genomic DNA was quantitated as the
number of dGs residues per 100 residues of dG or
as pmoles of dGs per 10 micrograms of DNA.
Nucleoside analysis of DNA hydrolysate by dual-wavelength HPLC is shown
in Fig. 2. Results of HPLC quantification of dGs in genomic DNA after 24 h of exposure
to 10 µM MP are summarized in Table 1
and depicted Fig. 1B. Despite higher sensitivity of the fluorometric
method, direct UV monitoring of thioguanosine at 340 nm was found to be
accurate and straightforward, thus this method was routinely used for
our experiments with DNA from cultured cells. As shown in Table 1,
dGs incorporation into DNA after 24 h
incubation with 10 µM MP varied more than 50-fold (range 0.045-2.8
dGs residues/100 dG residues) among these cell
lines (p < .02). However, among cells with HPRT
activity, there was not a significant correlation between the level of
dGs incorporation into DNA and the extent of
cytotoxicity at 72 h (Fig. 1, A and B; Spearman rank order
r = 0.2; p = .7).
|
|
Synthetic dGs-Containing Duplexes.
The presence of
dGs in oligodeoxyribonucleotides was confirmed by
spectral analysis (
max 260 and 340 nm) and
enzymatic hydrolysis to nucleosides followed by HPLC separation of the
reaction mixture under conditions similar to that for
dGs quantification in genomic DNA (see Fig. 2).
|
|
Inhibition of RNase H-Mediated Hydrolysis of
dGsContaining DNA-RNA Duplexes.
The influence of
dGs incorporation into the deoxy strand of hybrid
(DNA-RNA) duplexes on the activity of RNase H was assessed using
nonmodified and modified substrates (structures in Table 3). E. coli 5S ribosomal RNA
or its 13-mer fragment and complementary oligodeoxyribonucleotide
(natural and dGs-containing) heteroduplexes were
obtained by annealing (hybrid duplexes V-VIII in Table 3). Nuclear
extracts were prepared from the cell lines (CEM, P12, NALM6, Molt4, and
HeLa) used in the previous experiments on MP sensitivity and
dGs incorporation into DNA. Human RNase H present
in the nuclear extracts in Mg2+-containing buffer
(Frank et al., 1994
) and bacterial RNase H produced the same cleavage
pattern of RNA from the DNA-RNA heteroduplexes (Fig.
4). The products of the RNase H-mediated
cleavage of 5S rRNA and its 13-mer fragment were analyzed by PAAG
electrophoresis (Figs. 4 and 5). E. coli RNase H cleavage of 5S rRNA was used as a control, and its
hydrolysis efficiency was used to normalize the hydrolysis by cellular
nuclear extracts. Results of quantification of the hydrolysis of RNA by
nuclear extracts of human lymphoblastoid cell lines within the
dGs -DNA-RNA heteroduplex are summarized in Table
3, revealing significant reduction of RNase H cleavage of 5S RNA
(duplex 6) when dGs was incorporated in the DNA
strand (p < .00002, ANOVA).
|
|
|
1, +1, and +2), an effect evident with nuclear extracts from all cell
lines tested.
|
| |
Discussion |
|---|
|
|
|---|
Thiopurines are inactive prodrugs, requiring metabolism to
nucleotides to exert cytotoxicity (Elion, 1989
), with the principal mechanism of cytotoxicity requiring dGs
incorporation into DNA (Krynetski et al., 1996
; Krynetski and Evans,
1999
). dGs-5'-triphosphate
(dGs TP), a final metabolite of MP and TG,
is a good substrate for human DNA polymerases
,
, and
with
Kms similar to those of natural substrates
(Ling et al., 1992
). Incorporation of thioguanosine into DNA leads to
substantial morphological changes of chromatid and is probably
important for a number of MP and TG effects, including delayed
cytotoxicity (Maybaum and Mandel, 1981
, 1983
).
We initially investigated the relationship between cytotoxic effects of mercaptopurine and the level of dGs incorporation into DNA of human B- and T-lineage leukemic cells. These studies revealed substantial differences in the extent of dGs incorporation into DNA, with B-lineage cells incorporating less dGs than T-lineage cells (Table 1). Among all cell lines evaluated (n = 8), there was significant correlation between HPRT activity and the level of dGs incorporation into DNA after 24 h exposure to 10 µM MP (Spearman rank order r = 0.68; p = .0005). However, there was no relation between the level of dGs incorporation into DNA and the extent of cytotoxicity at 48 or 72 h after exposure to 10 µM MP (p > .7).
With the exception of HPRT-deficient cells that are resistant because
they do not form deoxythioguanosine nucleotides, the viability of cells
after 48 h did not correlate significantly with the activity of
two enzymes catalyzing the major anabolic (phosphoribosylation by HPRT,
p = .44) and catabolic (methylation by TPMT,
p = .8) pathways of MP. As evidenced by our and other results (Maybaum and Mandel, 1983
), cytotoxic effects of
thiopurines become evident after the second round of cell division
(Fig. 1). This indicates that initial incorporation of
dGs into DNA, quite notable after 24 h of
incubation with MP (Table 1), does not lead to immediate cell death and
therefore is not the sole mechanism for immediate cytotoxicity. After
48 h, cytotoxicity is prominent, suggesting that attempted
replication of the thioguanylated template is important for
cytotoxicity (Glaab et al., 1998
). To further elucidate the
mechanisms(s) by which thiopurines alter DNA replication and exert
cytotoxicity, we investigated the effect of thiopurine incorporation on
RNase H function, a key enzyme in DNA replication. Because human B- and
T-lineage leukemia cells manifest different sensitivity to antileukemia
agents, we used nuclear extracts from both human B- and T-lineage
lymphoblasts in our in vitro experiments to determine the effects of
dGs incorporation on RNase H interaction with
dGS-DNA-RNA heteroduplex.
Three types of thioguanylated substrates participate in the replication
process: double-stranded DNA, single-stranded DNA, and DNA-RNA
heteroduplexes (Bambara et al., 1997
). To determine the effects of
dGs incorporated into DNA, we synthesized
oligodeoxyribonucleotides containing dGs
incorporated into specific positions and prepared two types of oligonucleotide duplexes (dGs-deoxy-deoxy and
dGs-deoxy-ribo duplexes) as models for
GS-DNA and GS-DNA-RNA
heteroduplexes formed in cells following thiopurine treatment. These
model systems permitted assessment of changes in stability, structure,
and substrate properties of such modified nucleic acids. By determining
the thermal dependence of hypochromicity, we demonstrated that
incorporation of deoxy-6-thioguanosine
(dGS) into oligodeoxyribonucleotides
decreases the Tm by approximately 10°C
(compare duplexes I-II and III-IV in Table 2). Circular dichroism
spectra of undecamers and nonadecamers (Fig. 3) revealed typical B-DNA
spectra with a positive peak at 278 nm and a negative peak at 250 nm
(Ivanov et al., 1973
). However, there was a decrease in intensity of
the positive band in the CD spectrum of duplex II, and a decrease in
both the positive and negative bands for duplex IV. These spectral
changes are consistent with a decrease in rigidity of the duplex
molecule due to distortion away from B-DNA structure because
Gs is unable to form normal Watson-Crick base
pair with C residues on the complementary strand. Evidence for a
distorted B-type helix is present for both modified duplexes II or IV.
We hypothesize that modification of DNA by incorporation of
dGs, and formation of a
Gs-C pair instead of a G-C pair, causes local
structural distortions of B-form DNA. It was previously shown that pair
T4S-A slightly changes the CD spectrum, but
oligos containing T2S instead of T do not have a
B-DNA like spectrum (Connolly and Newman, 1989
). The presence of a
sulfur atom in the sixth position changes the geometry of the
Gs-C pair so that one hydrogen bond is 0.6×
longer, resulting in weakening of the other two hydrogen bonds or a
distinct propeller-like distortion (Saenger, 1984
). The exact nature of
distortions introduced by dGs to the double helix
structure remains to be determined through direct structural studies.
Nonetheless, such subtle structural changes can dramatically change
nucleotide-protein interactions, consistent with the inhibition of
RNase H activity that we observed.
To determine whether incorporation of dGs impairs
RNase H functions in normal replication of DNA along the modified
template, we used a chemically modified oligodeoxyribonucleotide strand in hybrid DNA-RNA duplexes. The enzyme RNase H catalyzes the hydrolysis of RNA from DNA-RNA heteroduplexes; this enzyme is uniformly present in
various organisms and plays an important role in DNA replication (Crouch, 1990
). RNase H from E. coli and retroviral origin
have been extensively characterized (Wintersberger, 1990
), including crystallographic structure (Yang et al., 1990
), but little is known
about the structure and properties of two classes of RNase H in higher
eucaryotes (Frank et al., 1994
). RNase H activity was previously
demonstrated in nuclear extracts from the human acute lymphoblastic
leukemia Molt4 cell line (Giles et al., 1995
) and in human
erythroleukemia K562 cells (Eder and Walder, 1991
). It was also
previously shown that modified oligodeoxyribonucleotides with inserted
2'-O-methylcytidine, 2'-deoxy-2'-fluoronucleosides, ribonucleosides, or
-oligonucleotides change the geometry of hybrid
duplexes, dramatically decreasing the hydrolytic efficiency of E. coli RNase H, and that the oligonucleotide structure influences the position of cleavage within the phosphodiester chain of RNA (Krynetskaya et al., 1991
; Schmidt et al., 1992
; Alekseev et al., 1996
). Previously, we characterized E. coli RNase
H-catalyzed hydrolysis of E. coli 5S rRNA in the presence of
complementary oligodeoxyribonucleotides (Schmidt et al., 1992
). In the
present work, we used the same well-established system to characterize RNase H-catalyzed cleavage of 5S rRNA or its fragment in
dGs-modified and nonmodified hybrid DNA-RNA duplexes.
As depicted in Fig. 4, RNase H from different sources (bacterial and human) hydrolyzed 5S rRNA in the presence of oligonucleotides 5'-d(ACCACCGCGCT) and 5'-d(ACCACCGsCGCT). Both oligonucleotides are complementary to the 15-25 fragment of 5S rRNA, and RNase H cleaves the RNA strand within the region involved in heteroduplex formation. The nonmodified duplex V results in multiple scission points with nuclear extracts from all cell lines tested. The cleavage products formed in the course of the reaction with RNase H from the nuclear extracts of HeLa, Molt4, CEM, and NALM6 are similar to those formed by E. coli RNase H. However, when dGs was incorporated in the deoxy strand of the heteroduplex VI, efficiency of RNase H-catalyzed cleavage was decreased 10-fold (Table 3). This may reflect more efficient formation of the complementary duplex with nonmodified oligodeoxyribonucleotide compared with its dGs counterpart. Surprisingly, an additional nonspecific activity resulting in formation of additional cleavage sites beyond the heteroduplex was detected in cellular nuclear extracts and was most pronounced in HeLa cells in the presence of dGs-undecanucleotide (Fig. 4).
Interestingly, in experiments with a short heteroduplex (13-mer
fragment of 5S rRNA and complementary undecadeoxyribonucleotides), we
also detected inhibition of RNase H-mediated RNA cleavage in the
presence of dGs-containing
oligodeoxyribonucleotide, but inhibition was not as dramatic as that
observed in the presence of 5S RNA with a high content of helical
structures (Table 3, duplex VII versus duplex VIII). In addition, the
reaction with this short heteroduplex revealed differences in the
cleavage pattern (Fig. 5). The number of cleavage fragments was
changed, with the inhibition of RNA phosphodiester bond cleavage
detected in the vicinity of the Gs · C
base pair. The notable degradation of the single stranded 13-mer by
nuclear extracts, in contrast to relatively stable 120-mer 5S rRNA
(Figs. 4 and 5) is evidently due to lack of secondary structure in the
former. Figure 6 depicts the level of RNase H-catalyzed cleavage of RNA
within duplex VIII, relative to the nonmodified substrate 7. Maximum
inhibition of RNA cleavage was detected in two phosphodiester bonds
adjacent to the Gs · C base pair (
1, +1)
and at position +2 (Fig. 6). Enhanced hydrolysis at more distant
phosphodiester bonds +5 and +6 may be attributed to predominant
interaction of RNase H with this part of the duplex, with no other
substrate available. This held true both for the human nuclear extracts
from NALM6, P12, and CEM, and the purified bacterial enzyme. We
postulate that the enzyme interacts with a limited region of the
heteroduplex outside the Gs · C base pair.
Taking into consideration the structural data suggesting interaction of
bacterial RNase H with the minor groove of the heteroduplex (Yang et
al., 1990
), we hypothesize 1) that incorporation of
dGs into the deoxy strand of the modified
heteroduplex alters the minor groove of the DNA-RNA heteroduplex, and
2) that human RNase H also binds to the heteroduplex similarly to the
bacterial enzyme, i.e., with the minor groove of the heteroduplex. Our
finding that dGs incorporation into DNA causes
significant impairment of RNase H cleavage of the DNA-RNA duplex, is
consistent with the hypothesis that impaired DNA replication across
thioguanylated DNA is the basis for delayed cytotoxic effects of
thiopurines. Because replication is a multistep process, and the
replication machinery encompasses many components, elucidation of
specific targets affected by thioguanosine incorporation into DNA is a
crucial step toward fully elucidating the mechanism(s) by which
thiopurines produce their antileukemic effects. The finding that
thiopurine incorporation into DNA inhibits RNase H function, raises the
intriguing possibility that these agents may perturb retroviral
replication, because these viruses require RNase H activity to
replicate. Incorporation of dGs into the first
strand of cDNA could inhibit subsequent hydrolysis of RNA in the
DNA-RNA hybrid and therefore arrest the early stages of viral
infection. Thus, the current studies have revealed a new
pharmacological effect for thiopurines, providing new insights to their
mechanism of cytotoxicity and suggesting other potential therapeutic effects.
| |
Acknowledgments |
|---|
We thank Dr. E. A. Romanova (Moscow State University, Russia) for her help in preparation of dGs-containing oligodeoxyribonucleotides and Y. Yanishevski for his expertise in statistical analysis.
| |
Footnotes |
|---|
Received April 5, 1999; Accepted July 14, 1999
Send reprint requests to: Dr. William E. Evans, St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105. E-mail: william.evans{at}stjude.org
| |
Abbreviations |
|---|
MP, 6-mercaptopurine; TG, 6-thioguanine; dGS, 6-deoxythioguanosine; RNase H, ribonuclease H; HPRT, hypoxanthine-guanine phosphoribosyl transferase; TPMT, thiopurine methyltransferase; DTT, dithiothreitol (treo-1,4-dimercapto-2,3-butanediol); PAAG, polyacrylamide gel; AMCA, N-[6-(7-amino-4-methylcoumarin-3-acetamido)hexyl]-3'-(2'-pyridyldithio)-propionamide.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
U Hindorf, M Lindqvist, C Peterson, P Soderkvist, M Strom, H Hjortswang, A Pousette, and S Almer Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease Gut, October 1, 2006; 55(10): 1423 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zaza, M. Cheok, W. Yang, J. C. Panetta, C.-H. Pui, M. V. Relling, and W. E. Evans Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment Blood, September 1, 2005; 106(5): 1778 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bohon and C. R. de los Santos Effect of 6-thioguanine on the stability of duplex DNA Nucleic Acids Res., May 19, 2005; 33(9): 2880 - 2886. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Krynetskaia, T. L. Brenner, E. Y. Krynetski, W. Du, J. C. Panetta, P. Ching-Hon, and W. E. Evans Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-/- Mice Mol. Pharmacol., August 1, 2003; 64(2): 456 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bohon and C. R. de los Santos Structural effect of the anticancer agent 6-thioguanine on duplex DNA Nucleic Acids Res., February 15, 2003; 31(4): 1331 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Somerville, E. Y. Krynetski, N. F. Krynetskaia, R. D. Beger, W. Zhang, C. A. Marhefka, W. E. Evans, and R. W. Kriwacki Structure and Dynamics of Thioguanine-modified Duplex DNA J. Biol. Chem., January 3, 2003; 278(2): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Krynetski, N. F. Krynetskaia, M. E. Bianchi, and W. E. Evans A Nuclear Protein Complex Containing High Mobility Group Proteins B1 and B2, Heat Shock Cognate Protein 70, ERp60, and Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in the Cytotoxic Response to DNA Modified by Incorporation of Anticancer Nucleoside Analogues Cancer Res., January 1, 2003; 63(1): 100 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. KRYNETSKAIA, J. Y. FENG, E. Y. KRYNETSKI, J. V. GARCIA, J. C. PANETTA, K. S. ANDERSON, and W. E. EVANS Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug FASEB J, September 1, 2001; 15(11): 1902 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dervieux, J. G. Blanco, E. Y. Krynetski, E. F. Vanin, M. F. Roussel, and M. V. Relling Differing Contribution of Thiopurine Methyltransferase to Mercaptopurine versus Thioguanine Effects in Human Leukemic Cells Cancer Res., August 1, 2001; 61(15): 5810 - 5816. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Krynetski, N. F. Krynetskaia, A. E. Gallo, K. G. Murti, and W. E. Evans A Novel Protein Complex Distinct from Mismatch Repair Binds Thioguanylated DNA Mol. Pharmacol., February 1, 2001; 59(2): 367 - 374. [Abstract] [Full Text] |
||||
![]() |
N. F. KRYNETSKAIA, X. CAI, J. L. NITISS, E. Y. KRYNETSKI, and M. V. RELLING Thioguanine substitution alters DNA cleavage mediated by topoisomerase II FASEB J, November 1, 2000; 14(14): 2339 - 2344. [Abstract] [Full Text] |
||||
![]() |
S. W. Tendian and W. B. Parker Interaction of Deoxyguanosine Nucleotide Analogs with Human Telomerase Mol. Pharmacol., April 1, 2000; 57(4): 695 - 699. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||